DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
AD1089845
Title:
Targeting Shiga Toxins for Treatment-resistant Bacterial Gut Infections
Corporate Author:
University of Utah Salt Lake City United States
Report Date:
2019-07-01
Abstract:
The purpose of this research is to identify a protease-resistant D-peptide inhibitor of Shiga toxin for use as an orally delivered prevention or therapeutic agent to treat severe bacterial gut infections caused by Shigella or Shiga toxin-producing E. coli STEC. During this period, we successfully synthesized the Shiga toxin B-subunit using solid-phase peptide synthesis and native chemical ligation. The N-terminal half of the protein suffers from poor solubility, so we developed a new helping hand solubilizing tag to enable isolation of this peptide and its ligation to the C-terminal half. This synthetic protein was folded into pentamers and validated using LCMS, circular dichroism, size-exclusion chromatography, and analytical ultracentrifugation. To overcome problems with instability of the pentamer, we developed a cork peptide that mimics the C-terminal tail of the natural Shiga A subunit. This peptide will stabilize the B-subunit pentamer by filling its central cavity. This stabilized pentamer will be used in mirror-image phage display to identify D-peptide inhibitors.
Descriptive Note:
Technical Report,01 Jul 2018,30 Jun 2019
Pages:
0029
Distribution Statement:
Approved For Public Release;
File Size:
1.01MB
